Skip to main content
OpenTrials
Completed

NCT Number: NCT00278694

Oxaliplatin and 5-FU Based Preoperative Chemoradiation

Oxaliplatin and 5FU based preoperative chemoradiation in rectal cancer.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

RRHF

Oslo, 0027, Norway

About this study

Effect of treatment, safety profile and quality of life scorings.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Rectal cancer

Treatment and study plan

Oxaliplatin

Drug

Chemoradiation

Drug

5-FU

Drug

Preoperative chemoradiation

Radiation

Pelvic surgery

Procedure

Neoadjuvant oxaliplatin

Drug

Primary outcomes

  1. Safety profile

    Time frame: 5 years

  2. Number of patients obtaining pCR

    Time frame: 5 years

Secondary outcomes

  1. Clinical, radiological and molecular response to treatment

    Time frame: 5 years

Sponsors and collaborators

Lead sponsor

Oslo University Hospital

Other

Registry information

Acronym: LARC-RRP

Important dates

Study start
2005
Primary completion
2016
Study completion
2016
First posted
Jan 18, 2006
Registry last updated
Sep 29, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.